KalVista Pharmaceuticals (KALV) Earnings Date & Reports

Industry: @Pharmaceuticals Other

A.I. Advisor

published Earnings

KALV is expected to report earnings to fall 12.25% to -89 cents per share on September 05

KalVista Pharmaceuticals KALV Stock Earnings Reports

Q3'24

Est.

$-0.89

Q2'24

Missed

by $0.31

Q1'24

Missed

by $0.09

Q4'23

Missed

by $0.04

Q3'23

Beat

by $0.14

The last earnings report on July 11 showed earnings per share of -101 cents, missing the estimate of -70 cents. With 1.83M shares outstanding, the current market capitalization sits at 533.28M.

View a ticker or compare two or three

Compare

KALV

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For KALV
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for KALV (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of pharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Pharmaceuticals Other

Address

55 Cambridge Parkway

Phone

+1 857 999-0075

Employees

118

Web

https://www.kalvista.com